Literature DB >> 25874916

Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression.

Brent P Forester1, David G Harper, Joanna Georgakas, Caitlin Ravichandran, Nethra Madurai, Bruce M Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25874916      PMCID： PMC4414830          DOI： 10.1097/JCP.0000000000000326

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  17 in total

1.  Mental health service use by elderly patients with bipolar disorder and unipolar major depression.

Authors:  S J Bartels; B Forester; K M Miles; T Joyce
Journal:  Am J Geriatr Psychiatry       Date:  2000       Impact factor: 4.105

Review 2.  Clinical trials of coenzyme Q10 in neurological disorders.

Authors:  Clifford W Shults; Richard Haas
Journal:  Biofactors       Date:  2005       Impact factor: 6.113

3.  A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

Authors:  Lewis L Judd; Hagop S Akiskal; Pamela J Schettler; William Coryell; Jean Endicott; Jack D Maser; David A Solomon; Andrew C Leon; Martin B Keller
Journal:  Arch Gen Psychiatry       Date:  2003-03

4.  New magnetic resonance spectroscopy biomarker for monitoring neurodegenerative diseases: animal models.

Authors:  Svatava Kasparová; Zuzana Sumbalová; Jaromír Horecký; Peter Bystrický; Vladimír Mlynárik; Anna Gvozdjáková; Tibor Liptaj
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2005-12       Impact factor: 1.245

5.  Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction.

Authors:  Ram B Singh; Narankar Singh Neki; Kumar Kartikey; Daniel Pella; Adarsh Kumar; Mohammad Arif Niaz; Amar Singh Thakur
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

6.  Coenzyme Q10 effects in neurodegenerative disease.

Authors:  Meredith Spindler; M Flint Beal; Claire Henchcliffe
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570

Review 7.  An analysis of the role of coenzyme Q in free radical generation and as an antioxidant.

Authors:  R E Beyer
Journal:  Biochem Cell Biol       Date:  1992-06       Impact factor: 3.626

8.  Molecular evidence for mitochondrial dysfunction in bipolar disorder.

Authors:  Christine Konradi; Molly Eaton; Matthew L MacDonald; John Walsh; Francine M Benes; Stephan Heckers
Journal:  Arch Gen Psychiatry       Date:  2004-03

9.  Relapse and impairment in bipolar disorder.

Authors:  M J Gitlin; J Swendsen; T L Heller; C Hammen
Journal:  Am J Psychiatry       Date:  1995-11       Impact factor: 18.112
View more
  12 in total

Review 1.  Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Authors:  G Morris; A J Walker; K Walder; M Berk; W Marx; A F Carvalho; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

Review 2.  Targeting the immune system in the treatment of bipolar disorder.

Authors:  Joshua D Rosenblat
Journal:  Psychopharmacology (Berl)       Date:  2019-02-13       Impact factor: 4.530

Review 3.  Targeting Mitochondrial Dysfunction for Bipolar Disorder.

Authors:  Maya Kuperberg; Sophie L A Greenebaum; Andrew A Nierenberg
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 4.  Comparative efficacy of mitochondrial agents for bipolar disorder during depressive episodes: a network meta-analysis using frequentist and Bayesian approaches.

Authors:  Rituparna Maiti; Archana Mishra; Biswa Ranjan Mishra; Monalisa Jena
Journal:  Psychopharmacology (Berl)       Date:  2021-11-09       Impact factor: 4.415

5.  Influence of adjuvant Coenzyme Q10 on inflammatory and oxidative stress biomarkers in patients with bipolar disorders during the depressive episode.

Authors:  Leila Jahangard; Fatemeh Yasrebifar; Mohammad Haghighi; Akram Ranjbar; Maryam Mehrpooya
Journal:  Mol Biol Rep       Date:  2019-07-25       Impact factor: 2.316

6.  A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression.

Authors:  Ricardo Alexandre Toniolo; Michelle Silva; Francy de Brito Ferreira Fernandes; José Antonio de Mello Siqueira Amaral; Rodrigo da Silva Dias; Beny Lafer
Journal:  J Neural Transm (Vienna)       Date:  2017-11-24       Impact factor: 3.575

Review 7.  The Endoplasmic Reticulum Stress Response in Neuroprogressive Diseases: Emerging Pathophysiological Role and Translational Implications.

Authors:  Gerwyn Morris; Basant K Puri; Ken Walder; Michael Berk; Brendon Stubbs; Michael Maes; André F Carvalho
Journal:  Mol Neurobiol       Date:  2018-03-29       Impact factor: 5.590

Review 8.  Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis.

Authors:  Gerwyn Morris; Edna Maria Vissoci Reiche; Andrea Murru; André F Carvalho; Michael Maes; Michael Berk; Basant K Puri
Journal:  Mol Neurobiol       Date:  2018-01-02       Impact factor: 5.590

Review 9.  Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments.

Authors:  Gerwyn Morris; Basant K Puri; Lisa Olive; Andre Carvalho; Michael Berk; Ken Walder; Lise Tuset Gustad; Michael Maes
Journal:  BMC Med       Date:  2020-10-19       Impact factor: 8.775

10.  A Review of the Evidence Base for Nutrition and Nutritional Supplements in Older Adults with Bipolar Disorder: A report from the OABD task force.

Authors:  A T Olagunju; J A Morgan; A Aftab; J R Gatchel; P Chen; A Dols; M Sajatovic; W T Regenold
Journal:  J Frailty Aging       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.